Cargando…
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
BACKGROUND: Fusobacterium nucleatum (F. nucleatum) is a gut microbe implicated in gastrointestinal tumorigenesis. Predicting the chemotherapeutic response is critical to developing personalised therapeutic strategies for oesophageal cancer patients. The present study investigated the relationship be...
Autores principales: | Liu, Yang, Baba, Yoshifumi, Ishimoto, Takatsugu, Tsutsuki, Hiroyasu, Zhang, Tianli, Nomoto, Daichi, Okadome, Kazuo, Yamamura, Kensuke, Harada, Kazuto, Eto, Kojiro, Hiyoshi, Yukiharu, Iwatsuki, Masaaki, Nagai, Yohei, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Komohara, Yoshihiro, Ohmuraya, Masaki, Wang, Xiaoming, Ajani, Jaffer A., Sawa, Tomohiro, Baba, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921654/ https://www.ncbi.nlm.nih.gov/pubmed/33299132 http://dx.doi.org/10.1038/s41416-020-01198-5 |
Ejemplares similares
-
Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021) -
Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019) -
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019) -
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018) -
Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)